Evidence map›Paper›PMID 39431488›Full record

ArticleChemSusChem2025

Post-Synthetic Modification of a MOF via Continuous Flow Methods for Gold E-Waste Recycling.

Jocelyn Roth, Olga Trukhina, Dalia Allouss, Dragos Stoian, Till Schertenleib, Timo Felder, Wendy L Queen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jocelyn RothInstitute of Chemical Sciences and Engineering, École Polytechnique Fedérale de Lausanne (EPFL), CH-1950, Sion, Switzerland.
Olga TrukhinaInstitute of Chemical Sciences and Engineering, École Polytechnique Fedérale de Lausanne (EPFL), CH-1950, Sion, Switzerland.
Dalia AlloussLaboratoire de Matériaux, Catalyse et Valorisation des Ressources Naturelles, URAC 24, FST, Université Hassan II-Casablanca, Casablanca, 28806, Morocco.
Dragos StoianSNBL/ESRF, CS40220 F-38043, Grenoble cedex, France.
Till SchertenleibInstitute of Chemical Sciences and Engineering, École Polytechnique Fedérale de Lausanne (EPFL), CH-1950, Sion, Switzerland.
Timo FelderInstitute of Chemical Sciences and Engineering, École Polytechnique Fedérale de Lausanne (EPFL), CH-1950, Sion, Switzerland.
Wendy L QueenInstitute of Chemical Sciences and Engineering, École Polytechnique Fedérale de Lausanne (EPFL), CH-1950, Sion, Switzerland.ORCID https://orcid.org/0000-0002-8375-2341

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
6 · The paper itself

Abstract

This work represents a pioneering effort in utilizing continuous flow methods for the post-synthetic modification of a nanoporous metal-organic framework (Fe-BTC or MIL-100(Fe)) with short-chain redox-active oligomers (poly-p-phenylenediamine, PpPDA). The Fe-BTC/PpPDA composite has been previously demonstrated to rapidly and selectively extract gold from complex liquids. Thus, in the present study, Fe-BTC/PpPDA was synthesized on a 250 g scale and tested in eight industrially relevant solutions used for leaching metals from electronic waste. These leachates (e. g., cyanide, thiourea, and aqua regia) exhibited varying effectiveness, pH, and gold speciation, which led to significant differences in the composite's performance during gold extraction. Notably, Fe-BTC/PpPDA performed best in leaching solutions containing [AuCl

Indexed as

BeadsBreakthrough gold recoveryContinuous flow polymerizationElectronic wasteMOF polymer composite

Identifiers

PMID39431488
PMCPMC11874704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.